To include your compound in the COVID-19 Resource Center, submit it here.

Microfocus APA 1000: Phase III started

Medifocus began an open-label, North American Phase III trial

Read the full 99 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE